Senior insider sale
Chief Medical Officer at DYNE THERAPEUTICS, INC. — senior position signals high conviction
$178.9K
7.44K shares
What this filing means
KERR DOUGLAS plans to sell 7.44K shares of DYNE THERAPEUTICS, INC. valued at approximately $178.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/4/2026ACC: 0001972481-26-000278
Officer· Chief Medical Officer
Since Mar 2026
7.44K
Shares to sell
$178.9K
Approx. market value
14.88K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock Units
Equity Compensation
9/4/2026
3KRestricted Stock Units
Equity Compensation
9/3/2026
11.88KTotal acquired14.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/4/2026 | Restricted Stock Units Equity Compensation | 3K | — |
9/3/2026 | Restricted Stock Units Equity Compensation | 11.88K | — |
| Total | 14.88K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.56K
Market value
$40.9K
8/13/2026
—Completed
Units to sell
887.00
Market value
$16.3K
6/16/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
5K
Market value
$121.7K
9/4/2026
Total
Units
7.44K
Value
$178.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/13/2026 | 1.56K | $40.9K | — | Completed |
6/16/2026 | 887.00 | $16.3K | — | Completed |
| Planned — Approximate Date | ||||
9/4/2026 | 5K | $121.7K | Nasdaq | Planned |
| Total | 7.44K | $178.9K | ||